Cargando…
WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells
SIMPLE SUMMARY: Breast cancer is the most frequent malignancy in women worldwide. Advanced breast cancer with distant organ metastases is considered incurable with currently available therapies. The vasculogenic mimicry (VM) process is associated with an invasive and metastatic cancer phenotype and...
Autores principales: | Ferrand, Nathalie, Fert, Aude, Morichon, Romain, Radosevic-Robin, Nina, Zaoui, Maurice, Sabbah, Michèle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945957/ https://www.ncbi.nlm.nih.gov/pubmed/35326638 http://dx.doi.org/10.3390/cancers14061487 |
Ejemplares similares
-
PARP Inhibitor Inhibits the Vasculogenic Mimicry through a NF-κB-PTX3 Axis Signaling in Breast Cancer Cells
por: Chivot, Justine, et al.
Publicado: (2022) -
WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity
por: Ferrand, Nathalie, et al.
Publicado: (2017) -
The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
por: Azad, Taha, et al.
Publicado: (2019) -
Loss of WISP2/CCN5 in Estrogen-Dependent MCF7 Human Breast Cancer Cells Promotes a Stem-Like Cell Phenotype
por: Ferrand, Nathalie, et al.
Publicado: (2014) -
Vasculogenic mimicry
por: Pandiar, Deepak, et al.
Publicado: (2023)